(XMME) Xtrackers MSCI Emerging - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Etf • ISIN: IE00BTJRMP35 • Global Emerging Markets Equity
XMME: Stocks, Bonds, Emerging Markets, Equities
The Xtrackers MSCI Emerging Markets UCITS ETF 1C CHF (SW:XMME) is a compelling option for those seeking exposure to emerging markets. As part of the Xtrackers suite managed by DWS, it offers a structured approach to accessing high-growth regions. Domiciled in Ireland, it benefits from a regulatory environment thats favorable for European ETFs, providing a stable foundation for investors.
This ETF tracks the Morningstar EM TME NR USD index, which encompasses a diverse range of large and mid-cap companies across various emerging markets. By spreading investments across multiple countries and sectors, it mitigates risk through diversification, a key consideration for any investor entering these dynamic but volatile markets.
With an AUM of 5733.81M CHF, this fund is well-established, indicating a level of investor confidence and liquidity. Its passively managed structure ensures lower fees, aligning with the cost-effective approach that many investors prefer. However, its crucial to recognize that emerging markets can experience significant volatility, making it essential for investors to assess their risk tolerance and investment horizon carefully.
For those considering this ETF, understanding the underlying index is paramount. Additionally, the CHF denomination necessitates consideration of currency risks, as the funds performance is influenced by fluctuations between the Swiss Franc and the US Dollar. A long-term perspective is advisable, allowing investors to navigate the inherent volatility and capture potential growth over time.
Additional Sources for XMME ETF
XMME ETF Overview
Market Cap in USD | 6,779m |
Category | Global Emerging Markets Equity |
TER | 0.18% |
IPO / Inception | 2017-06-21 |
XMME ETF Ratings
Growth 5y | 20.5% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | 3.73 |
Analysts | - |
Fair Price Momentum | 46.75 CHF |
Fair Price DCF | - |
XMME Dividends
No Dividends PaidXMME Growth Ratios
Growth Correlation 3m | 55.1% |
Growth Correlation 12m | 61.8% |
Growth Correlation 5y | -18.6% |
CAGR 5y | 7.11% |
CAGR/Max DD 5y | 0.21 |
Sharpe Ratio 12m | 0.89 |
Alpha | 1.95 |
Beta | 0.72 |
Volatility | 19.77% |
Current Volume | 58.2k |
Average Volume 20d | 27.6k |
As of March 14, 2025, the stock is trading at CHF 51.95 with a total of 58,248 shares traded.
Over the past week, the price has changed by -1.52%, over one month by -2.51%, over three months by -0.15% and over the past year by +9.55%.
Neither. Based on ValueRay Analyses, Xtrackers MSCI Emerging is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 20.51 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XMME as of March 2025 is 46.75. This means that XMME is currently overvalued and has a potential downside of -10.01%.
Xtrackers MSCI Emerging has no consensus analysts rating.
According to ValueRays Forecast Model, XMME Xtrackers MSCI Emerging will be worth about 52 in March 2026. The stock is currently trading at 51.95. This means that the stock has a potential upside of +0.13%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 52 | 0.1% |